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Abstract 
Despite the critical role of soluble IgE in the pathology of IgE-mediated allergic disease, little 
is known about abnormalities in the memory B-cells and plasma cells that produce IgE in 
allergic patients. We here applied a flowcytometric approach to cross-sectionally study blood 
IgE+ memory B-cells and plasmablasts in 149 children with atopic dermatitis, food allergy 
and/or asthma, and correlated these to helper-T(h)2 cells and eosinophils. Children with 
allergic disease had increased numbers of IgE+CD27- and IgE+CD27+ memory B-cells and 
IgE+ plasmablasts, as well as increased numbers of eosinophils and Th2 cells. IgE+ 
plasmablast numbers correlated positively with Th2 cell numbers. These findings open new 
possibilities for diagnosis and monitoring of treatment in patients with allergic diseases. 
 
Key words: Asthma, IgE, memory B-cell, plasmablast, flowcytometry 
 
Introduction 
IgE is commonly used in the diagnostic work-up of patients with allergic disease, but little is 
known about the cells producing it.1, 2 All antibodies, including IgE, are produced by plasma 
cells.3 IgM, IgG and IgA expressing memory B cells and plasma cells can be readily detected 
in tissue or blood of healthy children and adults. In contrast, IgE-expressing B cells have 
been enigmatic.4 Still, based on the presence of IgE transcripts isolated from various tissues 
and blood of healthy controls and allergic subjects5-7, the presence of IgE-expressing B cells 
has been anticipated.8 We developed a flowcytometric strategy that enabled the detection of 
IgE-expressing CD27+CD38hi plasmablasts, CD27+ and CD27- memory B cells.9 Although 
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T-cell help is required to generate the former subsets, CD27-IgE+ B cells can be formed 
independent of cognate T-cell help.9, 10 
More insights into IgE-expressing B cells and their interactions with other immune cells 
are needed to better understand the pathogenesis of allergic disease, which could be useful for 
diagnostic purposes or to uncover targets for treatment. Similar to immunotherapy, anti-IgE 
antibody treatment can potentially target IgE+ memory B-cells and thereby might resolve the 
underlying allergy.11 
We performed a cross-sectional study into IgE-expressing B cells in allergic children and 
healthy controls. Patients were separated into three groups based on distinct allergic 
phenotypes of asthma, food allergy and/or atopic dermatitis. We studied IgE+ memory B-cell 
and IgE+ plasmablast numbers with flow cytometry, their maturation status with molecular 
studies, and related these to clinical phenotype and other clinical and immunological 
parameters.  
 
Methods 
Peripheral blood samples were obtained from children aged 6-18 years who were recruited 
from the allergy outpatient clinics (KinderHaven and allergy department) of the Erasmus 
University Medical Center Rotterdam. All children were recruited from a tertiary referral 
center for children with allergic disease and were doctor’s diagnosed as moderate to severe 
allergic disease. All children had allergic disease based on clinical examination and 
confirmed either by atopy skin test (HEP >0.21), specific IgE serum levels (>0.35 IU/L), 
immune solid-phase allergy chip (ISAC) or, in the case of food-allergy, double blind food 
provocation test. Based on symptoms, clinical findings and IgE-specificity, children with 
allergic disease were divided into three groups: 1) children with asthma in absence of food 
allergy (FA) and atopic dermatitis (AD): ‘Asthma’, n=68; 2) children with asthma in 
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combination with FA and/or AD: ‘Asthma + FA/AD’, n=48; and 3) children with FA and/or 
AD in absence of asthma; ‘FA/AD’, n=33. Age-matched non-allergic controls were recruited 
among children undergoing surgery in the Sophia Children’s Hospital in Rotterdam. 
Exclusion criteria for the study were: age <6 years, systemic immunosuppressive therapy and 
immunological diseases, such as immunodeficiencies and auto-immune diseases. 
All peripheral blood samples were collected after written informed consent was obtained 
and with approval of the Medical Ethical Committee of the Erasmus Medical Center, which 
complies with the Helsinki declaration. 
Detailed methods on flow cytometry, molecular analysis of IgE transcripts and statistics 
can be found in Appendix S1. 
 
Results 
Patient characteristics 
A total of 149 allergic and 15 non-allergic children were included. All allergic children were 
sensitized for either aero- or food-allergens, as detailed per group in Table S1.  
 
Increased numbers of eosinophils, T-cells and B-cells in children with allergic disease 
Total leukocyte counts were higher in patients with allergic disease than in non-allergic 
controls (Figure 1A). Similarly, total T- and B-cell numbers were significantly higher in each 
of the 3 groups with allergic disease than in non-allergic controls (Figure 1B). Total numbers 
and frequencies of eosinophils were significantly increased in allergic children as compared 
to non-allergic children (Figure 1C and Figure S2). Leukocyte subsets and total T- and B-cell 
numbers did not differ between the three allergic groups. 
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Absolute CD4+ T-cell numbers and subsets within CD4+ T-cells were significantly 
higher in children with allergic disease than in non-allergic children (Figure 1D). Still, 
frequencies of CD4 T-cells within CD3+ T-cell were not different from healthy children 
(Figure 1E). In addition, frequencies of Th1 and Th2 subsets within CD4+ T cells were not 
different between healthy children and children with allergic disease (Figure 1F). As a result, 
we did not observe a difference in Th2/Th1 cell ratios (Figure 1G) between patients and 
controls. 
 
Increased numbers of circulating IgE+ memory B-cells and IgE producing plasmablasts 
IgE+ memory B-cells were defined within the CD19+CD38dim fraction and IgE+ plasmablasts 
within the CD19+CD38+CD27hi fraction following exclusion of CD19+ B-cells expressing 
IgM, IgD, IgA or IgG (Figure 2A).9  
Median cell numbers of both CD27+IgE+ and CD27-IgE+ memory B-cells were 
significantly higher in all three groups of allergic children than in non-allergic controls 
(Figure 2B). In addition, IgE+ plasmablast numbers were significantly increased in allergic 
children (Figure 2C). IgE+ memory B-cell and IgE+ plasmablast numbers did not 
significantly differ between patient groups. The increases in IgE+ B-cell numbers in allergic 
children were not only the result of higher total B-cell counts, because their relative numbers 
within CD19+ B cells were also significantly higher in all patient groups (Figure 2D,E). 
To investigate whether the increased numbers constituted normal plasmablasts, we 
studied the levels of somatic hypermutation (SHM) in IgE transcripts of sorted cells from 
allergic children (n=43 unique transcripts) and from non-allergic controls (n=34 unique 
transcripts). Transcripts from patients carried fewer mutations in their IGHV genes than 
controls (Figure 2F). As a measure for antigen-driven selection of the mutations in the IGHV 
genes, we analyzed the selection for replacement mutations in the complementarity 
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determining regions (CDR) with the BASELINe program. Transcripts from healthy controls 
(PCDR/FWR -0.48) nor from children with allergic disease (PCDR/FWR 0.06) showed more 
replacement mutations than expected by random chance in the CDR regions, i.e. absence of 
positive selection (Figure 2G). Thus, the higher numbers of circulating IgE-expressing B-
cells in children with allergic disease did not show molecular signs of enhanced antigen 
receptor maturation. 
Since type 2 cytokines produced by helper-T(h) cells are important for IgE class switch 
recombination (CSR) and children with allergic disease had increased numbers of IgE+ B-
cells, we investigated the correlation between Th cells and IgE+ B-cells. We observed a 
correlation between IgE+ plasmablast numbers and Th2 cells (r 0.271; P <0.01), whereas 
there was no correlation between IgE+ memory B-cell subsets and Th2 cells (Figure 2H).  
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Discussion 
In the present study we extended the immunological phenotype of allergic children. In 
addition to Th2 cells, eosinophils, basophils and serum IgE, we found increased numbers of 
circulating IgE+ memory cells and IgE+ plasmablasts, and a positive correlation between 
IgE+ plasmablasts and Th2 cell numbers.  
In our patient group, type 2 sensitization was confirmed by high IgE serum levels, 
sensitization to various aero- and food allergens, high numbers of eosinophils in blood and 
increased Th2 cell numbers.  
Our findings of increased numbers of circulating IgE+ memory B cells extend previous 
observations.9, 12, 13 Importantly, our flowcytometric gating strategy enabled exclusion of IgE-
binding cells from the true IgE-expressing B cells, which we confirmed by the presence of 
mature IgE transcripts. We showed that this occurs in children, and is independent of the 
allergic phenotype. A cause for the increased numbers of circulating IgE+ memory B cells 
could be the chronic inflammation. This is specifically thought to occur in patients with 
atopic dermatitis, and to some extent also in asthma. Here we found increased numbers of 
both CD27+ and CD27- IgE-expressing memory B cells in allergic patients. It has been 
shown that CD27- IgE+ memory B-cells display a limited proliferation history and lower 
SHM levels in their immunoglobulin genes9, which suggest that they originate from mucosal 
tissue, analogous to CD27-IgA+ memory B-cells.14 This is supported by previous detections 
of IgE transcripts and Sµ-Sε switch circles in nasal tissue of patients with allergic rhinitis and 
in bronchial tissue of patients with allergic asthma.8, 15 Several studies have shown that 
sensitized individuals who are exposed to allergens via nasal tissue or the respiratory tract, 
display a substantial increase in systemic serum IgE levels, thus indicating the direct 
activation of an established local pool of IgE memory cells with defined specificities as an 
underlying mechanism.16  
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We did not observe a correlation between IgE+ memory B-cell and Th2 cell numbers, 
but we did find a positive correlation between Th2 cells and IgE+ plasmablasts. Previous 
studies show that type 2 innate lymphoid cells (ILC2) might play an important role in the 
local CSR towards IgE.17, 18 Furthermore expansions of ILC2 populations have been observed 
in allergic disease and are known to produce type 2 cytokines and ILC2 cells facilitate 
sensitization to local, but not systemic Th2 inducing allergen exposures.19 Next to that, T 
follicular helper (Tfh) cells have been linked to IgE class switching through the production of 
IL-4.20, 21 Tfh cells express the B-cell follicle homing receptor CXCR5 and mainly reside in 
germinal centers. Thus possibly ILC2 cells might be important in local IgE CSR, Tfh cells in 
germinal center IgE CSR, whereas Th2 cells are important in plasma cell differentiation. In 
future studies it would be interesting to study ILC2 cells in mucosal tissue and correlate these 
to IgE+ memory B-cell numbers. 
It is uncertain if circulating IgE+ memory B-cells sustain the underlying allergy, but in 
vitro stimulated IgE+ memory B-cells can differentiate into IgE+ plasma cells.9 Therefore it 
is possible that increased circulating IgE+ memory B-cells actively contribute to allergic 
disease.22 To achieve desensitization and possibly even cure allergic disease, it might 
therefore be important to develop therapies to reduce IgE+ memory B-cells. Omalizumab 
treatment in humans has shown to decrease serum IgE in patients with IgE-mediated 
asthma23, however it mainly targets soluble IgE. This is not the case for Quilizimab, which 
only recognizes surface-expressed IgE on B cells11, and has shown to deplete IgE producing 
B-cells in mouse studies.24 Although human clinical trials with Quilizimab reduced IgE 
serum levels for 6 months after treatment cessation, the effects on clinical parameters were 
variable.25, 26 Our present findings can possibly contribute to patient selection and treatment 
monitoring of anti-IgE treatment.  
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Figure legends (n=2) 
 
Figure 1. Absolute numbers and frequencies of leukocyte subsets and CD4+ helper-T(h) 
subsets. A. White blood cell count. B. Absolute numbers of T cells and B cells. C. 
Percentages of granulocyte subsets and monocytes within total CD45+ cells. D. Absolute cell 
numbers of CD4+ T-cells, Th1 and Th2 cells E. Percentage of CD4+ T-cells within total 
CD3+ T-cells. F. Percentage of Th1 and Th2 cells within total CD3+ T-cells. G. ratio of 
Th2/Th1 cells. Each dot represents one individual and red lines indicate median values. Grey 
surface represent reference values. Statistical analysis was performed with Mann Whitney U 
test. *P<0.05, **P<0.01, ***P<0.001 
 
Figure 2. IgE+ B-cell subsets. A. Representative flowcytometry image and gating strategy of 
IgE+ memory B-cells. B. Absolute numbers and percentages of IgE+ memory B-cells. C. 
Absolute numbers and percentages of IgE+ plasmablasts. D. Somatic hypermutation (SHM) 
levels in the IGHV gene of IgE+ plasmablasts from healthy children and children with 
allergic disease (n=5 children each). E. Selection for replacement mutations in the CDR (red) 
and FR (blue) regions. F. Correlation of Th2 cell numbers with IgE+CD27-, IgE+CD27+ and 
IgE+ plasmablasts in children with allergic disease. In panels B, C and F each dot represents 
one individual; red lines indicate median values; and black lines in panel F indicate linear 
correlations. Statistical analysis was performed with Mann Whitney U test. *P<0.05, 
**P<0.01, ***P<0.001, ****P<0.0001. Correlation was calculated with Spearman R.  
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